Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Bullboard Posts
Post by johnny007on Dec 13, 2017 4:26am
100 Views
Post# 27144245

Good Stuff, Expect a Pullback Until News Get Out

Good Stuff, Expect a Pullback Until News Get OutGreat moves, good Stuff.
I expect a pullback until news get out, since stock price moved
already high above D 20ma and a bit over D 8ema.
Hence it is not much of a pullback, keeping it bullish but when no news
hit before 12/27 I expect profit taking.

I keep my set of FOMO shares of course, but sold a bunch again yesteday,
since I saw declining volume and lower highs / higher lows consolidation.
The latter is of course also quite bullish and SP might hold at 16c?

Conclusion, last buy at 14c was awesome and next buy 15c - 16c might be
awesome again :)

Sure, when the news hit - this will go above 20c!!!
Bullboard Posts